Relation of Low Serum Magnesium to Mortality and Cardiac Allograft Vasculopathy Following Heart Transplantation
Hypomagnesemia is commonly observed in heart transplant (HT) recipients receiving calcineurin inhibitors. Since low serum magnesium (s-Mg) has been implicated in the progression of atherosclerosis, potentially leading to worsening coronary heart disease, arrhythmias and sudden death, we investigated the association between s-Mg and HT outcomes. Between 2002 and 2017, 150 HT patients assessed for s-Mg were divided into high ( ≥1.7 mg/dL) and low s-Mg groups according to the median value of all s-Mg levels recorded during the first 3 months post-HT.
Source: The American Journal of Cardiology - Category: Cardiology Authors: Eilon Ram, Jacob Lavee, Michael Shechter, Alexander Kogan, Elad Maor, Elad Asher, Dov Freimark, Robert Klempfner, Yael Peled Source Type: research
More News: Arrhythmia | Bone Graft | Cardiology | Coronary Heart Disease | Heart | Heart Disease | Heart Transplant | Magnesium | Transplant Surgery | Transplants